Hao Wang

Bacterial infections are a common problem associated with wound treatment that imposes a significant burden on healthcare systems and patients. As a result, healthcare providers urgently need new treatment strategies to protect people. Hydrogel biomaterials with inherent antimicrobial properties offer an attractive and viable solution to this issue. Here, for the first time, we have developed a new efficient synthetic strategy to prepare cationic hydrogels (PHCI) with intrinsically efficient antimicrobial properties by chemically cross-linking trans-1,4-cyclohexanediamine with 1,3-dibromo-2-propanol using a condensation reaction without the use of toxic cross-linking agents. As expected, the prepared PHCI hydrogel possessed an inherent antibacterial ability that can adsorb and kill Staphylococcus aureus and Escherichia coli electrostatically. Notably, in vivo experiments on normal and diabetic rat models confirmed that the PHCI hydrogel can quickly stop bleeding, efficiently kill bacteria, promote the conversion of macrophages from the proinflammatory M1 phenotype to the repaired M2 phenotype, and accelerate collagen deposition and blood vessel formation, thereby achieving rapid wound healing. Overall, this work presents an effective antibacterial dressing that might provide a facile but effective approach for clinical wound management.

Inspired by the remarkable adhesion of mussel, dopamine, a mimicking adhesive molecule, has been widely used for surface modification of various materials ranging from organic to inorganic. However, dopamine and its derivatives are expensive which impede their application in large scale. Herein, we replaced dopamine with low-cost catechol and polyamine (only 8% of the cost of dopamine), which could be polymerized in an alkaline solution and deposited on the surfaces of various materials. By using this cheap and simple modification method, polypropylene (PP) separator could be transformed from hydrophobic to hydrophilic, while the pore structure and mechanical property of the separator remained intact. The uptake of electrolyte increased from 80% to 270% after the hydrophilic modification. Electrochemical studies demonstrated that battery with the modified PP separator had a better Coulombic efficiency (80.9% to 85.3%) during the first cycle at a current density of 0.1 C, while the discharging current density increased to 15 C and the discharge capacity increased by 1.4 times compared to the battery using the bare PP separator. Additionally, the modification allowed excellent stability during manifold cycles. This study provides new insights into utilizing low-cost chemicals to mimic the mussel adhesion and has potential practical application in many fields.

Despite the fact that pathogenic infections are widely treated by antibiotics in the clinic nowadays, the increasing risk of multidrug-resistance associated with abuse of antibiotics is becoming a major concern in global public health. The increased death toll caused by pathogenic bacterial infection calls for effective antibiotic alternatives. Lysozyme-coated mesoporous silica nanoparticles (MSNs⊂Lys) are reported as antibacterial agents that exhibit efficient antibacterial activity both in vitro and in vivo with low cytotoxicity and negligible hemolytic side effect. The Lys corona provides multivalent interaction between MSNs⊂Lys and bacterial walls and consequently raises the local concentration of Lys on the surface of cell walls, which promotes hydrolysis of peptidoglycans and increases membrane-perturbation abilities. The minimal inhibition concentration (MIC) of MSNs⊂Lys is fivefold lower than that of free Lys in vitro. The antibacterial efficacy of MSNs⊂Lys is evaluated in vivo by using an intestine-infected mouse model. Experimental results indicate that the number of bacteria surviving in the colon is three orders of magnitude lower than in the untreated group. These natural antibacterial enzyme-modified nanoparticles open up a new avenue for design and synthesis of next-generation antibacterial agents as alternatives to antibiotics.